Brief: Senti Biosciences, Inc. Q2 EPS USD -0.42
11/08/2023 13:37
Aug 11 (Reuters) - Senti Biosciences, Inc. Q2 basic EPS USD -0.42. * Q2 net income USD -18.697 million * Q2 EPS USD -0.42
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates